Literature DB >> 29797167

Cementless total hip arthroplasty for osteonecrosis and osteoarthritis produce similar results at ten years follow-up when matched for age and gender.

Yusuke Osawa1, Taisuke Seki2, Yasuhiko Takegami2, Taiki Kusano2, Kazuya Makida2, Naoki Ishiguro2.   

Abstract

PURPOSE: The aim of this study was to compare the clinical outcomes of cementless total hip arthroplasty (THA) used for the treatment of osteonecrosis of the femoral head (ONFH) and for osteoarthritis (OA) at a mean ten years follow-up.
METHODS: Case-control study of 78 patients (86 hips) who underwent THA for ONFH treatment (ONFH group). Patients were matched for age and sex to 78 patients (86 hips) who underwent THA for OA (OA group). We compared the clinical and patient-reported outcomes, implant survival rates, and rates of complications between the groups.
RESULTS: There were no between-group differences in the Harris Hip Score and in the following patient-reported outcomes at the last follow-up: Japanese Orthopedic Association Hip-Disease Evaluation Questionnaire (JHEQ) pain and movement scores and the Physical Component Summary and Role/Social Component Summary scores of Short Form-36 (SF-36). However, the mental score of the JHEQ, the Mental Component Summary score of SF-36, and The Visual Analog Scale score for satisfaction were lower for the ONFH group than for OA group. The rate of complication was equivalent between the groups: 5% for the ONFH group and 3% for the OA group. The ten year implant survival rate was equivalent between the groups, at 97.5% for the ONFH group and 98.2% for the OA group.
CONCLUSION: The functional outcomes, implant survival, and rate of complications for cementless THAs are comparable at a mean follow-up of ten years for ONFH and OA.

Entities:  

Keywords:  Cementless total hip arthroplasty; Comparative study; Osteoarthritis; Osteonecrosis of the femoral head

Mesh:

Year:  2018        PMID: 29797167     DOI: 10.1007/s00264-018-3987-7

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  25 in total

1.  Diagnostic criteria for non-traumatic osteonecrosis of the femoral head. A multicentre study.

Authors:  N Sugano; T Kubo; K Takaoka; K Ohzono; T Hotokebuchi; T Matsumoto; H Igarashi; S Ninomiya
Journal:  J Bone Joint Surg Br       Date:  1999-07

2.  Birmingham Hip Resurfacing vs Total Hip Arthroplasty: A Matched-Pair Comparison of Clinical Outcomes.

Authors:  Victor R Ortiz-Declet; David A Iacobelli; Leslie C Yuen; Itay Perets; Austin W Chen; Benjamin G Domb
Journal:  J Arthroplasty       Date:  2017-06-23       Impact factor: 4.757

3.  Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan.

Authors:  S Fukuhara; S Bito; J Green; A Hsiao; K Kurokawa
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

4.  Osteonecrosis of the femoral head treated with cementless total hip arthroplasty. A comparison with other diagnoses.

Authors:  K H Chiu; W Y Shen; C K Ko; K M Chan
Journal:  J Arthroplasty       Date:  1997-09       Impact factor: 4.757

5.  Dislocations after total hip-replacement arthroplasties.

Authors:  G E Lewinnek; J L Lewis; R Tarr; C L Compere; J R Zimmerman
Journal:  J Bone Joint Surg Am       Date:  1978-03       Impact factor: 5.284

6.  A prospective cohort study of the clinical presentation of non-traumatic osteonecrosis of the femoral head: spine and knee symptoms as clinical presentation of hip osteonecrosis.

Authors:  Jean-Philippe Hauzeur; Michel Malaise; Viviane de Maertelaer
Journal:  Int Orthop       Date:  2016-01-05       Impact factor: 3.075

7.  Do femoral head collapse and the contralateral condition affect patient-reported quality of life and referral pain in patients with osteonecrosis of the femoral head?

Authors:  Yusuke Osawa; Taisuke Seki; Yasuhiko Takegami; Takehiro Kasai; Yoshitoshi Higuchi; Naoki Ishiguro
Journal:  Int Orthop       Date:  2018-03-09       Impact factor: 3.075

8.  Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JHEQ): a patient-based evaluation tool for hip-joint disease. The Subcommittee on Hip Disease Evaluation of the Clinical Outcome Committee of the Japanese Orthopaedic Association.

Authors:  Tadami Matsumoto; Ayumi Kaneuji; Yoshimitsu Hiejima; Hajime Sugiyama; Haruhiko Akiyama; Takashi Atsumi; Masaji Ishii; Kiyoko Izumi; Toru Ichiseki; Hiroshi Ito; Takahiro Okawa; Kenji Ohzono; Hiromi Otsuka; Shunji Kishida; Seneki Kobayashi; Takeshi Sawaguchi; Nobuhiko Sugano; Ikumasa Nakajima; Shigeru Nakamura; Yukiharu Hasegawa; Kanji Fukuda; Genji Fujii; Taro Mawatari; Satoshi Mori; Yuji Yasunaga; Masao Yamaguchi
Journal:  J Orthop Sci       Date:  2011-11-02       Impact factor: 1.601

9.  Increased risk of revision in patients with non-traumatic femoral head necrosis.

Authors:  Camilla Bergh; Ann M Fenstad; Ove Furnes; Göran Garellick; Leif I Havelin; Søren Overgaard; Alma B Pedersen; Keijo T Mäkelä; Pekka Pulkkinen; Maziar Mohaddes; Johan Kärrholm
Journal:  Acta Orthop       Date:  2013-12-20       Impact factor: 3.717

10.  Implant survival and radiographic outcome of total hip replacement in patients less than 20 years old.

Authors:  Masako Tsukanaka; Vera Halvorsen; Lars Nordsletten; Ingvild Ø EngesæTer; Lars B EngesæTer; Anne Marie Fenstad; Stephan M Röhrl
Journal:  Acta Orthop       Date:  2016-07-20       Impact factor: 3.717

View more
  9 in total

1.  Hip osteonecrosis: stem cells for life or behead and arthroplasty?

Authors:  Philippe Hernigou; Gildasio Daltro; Jacques Hernigou
Journal:  Int Orthop       Date:  2018-06-08       Impact factor: 3.075

Review 2.  [Total hip replacement in avascular femoral head necrosis].

Authors:  M Betsch; M Tingart; A Driessen; V Quack; B Rath
Journal:  Orthopade       Date:  2018-09       Impact factor: 1.087

3.  Primary total hip replacement in Ficat-Arlet stage 3 and 4 osteonecrosis: a retrospective study at a minimum 12-year follow-up.

Authors:  Roger Erivan; Thomas Caputo; Hicham Riouach; Guillaume Villatte; Bruno Perreira; Stéphane Descamps; Stéphane Boisgard
Journal:  Eur J Orthop Surg Traumatol       Date:  2020-02-27

4.  Surgery trends for osteonecrosis of the femoral head: a fifteen-year multi-centre study in Japan.

Authors:  Shinya Kaneko; Yasuhiko Takegami; Taisuke Seki; Wakaba Fukushima; Takashi Sakai; Wataru Ando; Naoki Ishiguro; Nobuhiko Sugano
Journal:  Int Orthop       Date:  2020-01-23       Impact factor: 3.075

5.  Cell therapy for osteonecrosis of femoral head and joint preservation.

Authors:  You Seung Chun; Dong Hwan Lee; Tae Gu Won; Chan Sik Kim; Asode Ananthram Shetty; Seok Jung Kim
Journal:  J Clin Orthop Trauma       Date:  2021-11-27

6.  Hip function in patients undergoing conservative treatment for osteonecrosis of the femoral head.

Authors:  Yusuke Osawa; Yasuhiko Takegami; Daisaku Kato; Masanori Okamoto; Hiroki Iida; Shiro Imagama
Journal:  Int Orthop       Date:  2022-09-14       Impact factor: 3.479

7.  Total Hip Arthroplasty via direct anterior approach for osteonecrosis; comparison with primary hip osteoarthritis in a mid term follow up.

Authors:  Alireza Moharrami; Seyed Peyman Mirghaderi; Shahin Marzban; Seyed Mir Mansour Moazen-Jamshidi; Delaram Shakoor; Seyed Mohammad Javad Mortazavi
Journal:  J Clin Orthop Trauma       Date:  2022-10-03

8.  Effect of trochanter displacement on impingement and bone contact in total hip arthroplasty performed after curved intertrochanteric varus osteotomy for osteonecrosis of the femoral head: a simulation study.

Authors:  Masanori Okamoto; Taisuke Seki; Yasuhiko Takegami; Yusuke Osawa; Shiro Imagama
Journal:  BMC Musculoskelet Disord       Date:  2022-09-08       Impact factor: 2.562

9.  One-stage simultaneous hip-preserving surgeries for the management of bilateral femoral head osteonecrosis: a mean 7.0-year follow-up.

Authors:  Wenjun Feng; Pengcheng Ye; Shihao Ni; Peng Deng; Lu Lu; Jinlun Chen; Jianchun Zeng; Xinyu Qi; Jie Li; Ke Jie; Houran Cao; Zhijun Yue; Haitao Zhang; Yirong Zeng
Journal:  J Orthop Surg Res       Date:  2019-12-21       Impact factor: 2.359

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.